Epi Soul logo image Epi Soul logo image
  1. UW Home |
  2. SPH  |
  3. Other Departments |
Loading
online giving





































Epi Special Seminar

backBack to Epi Seminars

Tuesday, May 4, 2010
Genome Sciences Building
GENOM S060
3:30 to 4:50pm

Multi-center efficacy trial of antiretroviral prophylaxis among HIV discordant couples in east Africa.

Baeten  

Jared Baeten, MD, PhD

Dr. Baeten is an assistant professor in the Departments of Global Health and Medicine and an adjunct assistant professor in the Department of Epidemiology at the University of Washington.  His research focuses on epidemiologic and biologic risk factors for HIV and other sexually transmitted diseases, and clinical trials for prevention of HIV transmission. 

 

Dr. Baeten is Co-Chair and Medical Director of a phase III randomized, placebo-controlled trial of antiretroviral pre-exposure prophylaxis (PrEP), using oral tenofovir and co-formulated emtricitabine/tenofovir, for the prevention of HIV acquisition within HIV serodiscordant couples in Kenya and Uganda.  He is Project Director of an NIH grant studying combination HIV prevention strategies for the heterosexual African HIV epidemic.  Recently-completed studies for which he is a co-investigator include two phase III trials of suppressive treatment of genital herpes for prevention of HIV acquisition and transmission in high-risk populations in Africa, South America, and the U.S.  Collaborative projects exploring virologic and immunologic factors influencing HIV transmission are ongoing.  For the past 13 years, he has also worked with investigators from Seattle and Kenya on longitudinal studies of HIV acquisition and early HIV infection in a cohort of high-risk women in Mombasa, Kenya.


Suggested readings:

 

Updated on March 18, 2010